Cargando…
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed wit...
Autores principales: | Huang, Hui, Xiong, Ying, Wu, Zhensheng, He, Yuhui, Gao, Xianglin, Zhou, Zhangyan, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196466/ https://www.ncbi.nlm.nih.gov/pubmed/32107877 http://dx.doi.org/10.1002/mgg3.1193 |
Ejemplares similares
-
miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020) -
Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
por: Bai, Xiaoming, et al.
Publicado: (2019) -
MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1
por: Yu, Chao, et al.
Publicado: (2015) -
Silencing of microRNA-138-5p promotes IL-1β-induced cartilage degradation in human chondrocytes by targeting FOXC1: miR-138 promotes cartilage degradation
por: Yuan, Y., et al.
Publicado: (2016) -
MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B
por: Liu, Lina, et al.
Publicado: (2023)